1
A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older
Condition(s):Allergic Rhinitis; Perennial Allergic RhinitisLast Updated:June 13, 2012Completed